Shortlist review

Choose an award category: 

Back | Best Investor Communication Award | Best Use of AIM Award | Best Technology Award | AIM Transaction of the Year Award | AIM Corporate Governance Award | AIM Growth Business of the Year Award | Best Newcomer Award | Entrepreneur of the Year Award | Company of the Year Award 

Please note that the Best Performing Share Award is factual and therefore no shortlist is necessary 

AIM Transaction of the Year Award

Sponsored by | Shore Capital 



Amryt Pharma plc 

Amryt is a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. The group comprises a growing commercial business and a significant development pipeline.

Amryt's lead development candidate, FILSUVEZ® is a potential treatment for the cutaneous manifestations of EB, a rare and distressing genetic skin disorder affecting young children and adults for which there is currently no approved treatment. In September 2020, Amryt reported positive top line results from its pivotal global phase 3 trial of FILSUVEZ® in EB. FILSUVEZ® had been granted Rare Pediatric Disease Designation and had also received a Fast Track Designation from the U.S. Food and Drug Administration.



Codemasters Group Holdings plc 

Codemasters is a video game developer and publisher, specialising in high quality racing games. Headquartered in Southam, Warwickshire, the company is one of the most recognised British game developers and publishers, with a 30 year track record of producing successful games.

Codemasters is the home of revered franchises including DiRT, GRID and the F1® series of video games. In November 2019, the group acquired Slightly Mad Studios and added the award-winning Project CARS franchise to its portfolio alongside Fast & Furious Crossroads.


Inspiration Healthcare Group plc 

Inspiration Healthcare is a global supplier of medical technology for critical care, operating theatre and home healthcare applications. Its mission is to provide high quality innovative products to patients and caregivers around the world that help to improve patient outcomes and efficiencies of healthcare organisations with patient focused customer service and technical support.

The group’s own brand of critical care solutions span non-invasive respiratory management, thermoregulation and patient warming for newborns through to adults in intensive care and the operating theatre, whilst its distribution business in the UK and Ireland supplies solutions to support specialised surgical procedures and infusion therapies.



Kape Technologies plc 

Kape is a leading ‘privacy-first’ digital security software provider to consumers. Through its range of privacy and security products, the group focusses on protecting consumers and their personal data as they go about their daily digital lives.

To date, Kape has millions of paying subscribers, supported by a team of over 350 people across eight locations worldwide. Through its subscription based platform, Kape has fast established a highly scalable SaaS-based operating model, geared towards capitalising on the vast global consumer digital privacy market.